(PCRX) Pacira BioSciences - Performance -16% in 12m
PCRX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-42.20%
#97 in Peer-Group
Rel. Strength
26.15%
#5476 in Stock-Universe
Total Return 12m
-16.02%
#120 in Peer-Group
Total Return 5y
-54.36%
#106 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 9.62 |
| High / Low | USD |
|---|---|
| 52 Week High | 28.61 USD |
| 52 Week Low | 11.70 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 26.91 |
| Buy/Sell Signal +-5 | 0.84 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: PCRX (-16%) vs XLV (-5.4%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
2.4% | 125% | 327% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.69% | 17.7% | 78.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
4.34% | -14.2% | 404% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.15% | 2.99% | 49.2% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-7.83% | 4.46% | 46.4% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-6.3% | -5% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-2.85% | -8.53% | 45.7% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-1.19% | -10.7% | 41.1% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: PCRX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for PCRX
| Total Return (including Dividends) | PCRX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -8.92% | 2.04% | 4.55% |
| 3 Months | -3.82% | -7.24% | 10.78% |
| 12 Months | -16.02% | -5.41% | 14.71% |
| 5 Years | -54.36% | 43.58% | 112.53% |
| Trend Score (consistency of price movement) | PCRX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -86.8% | 34.5% | 79.2% |
| 3 Months | -10.7% | -46.5% | 92.9% |
| 12 Months | 71.3% | -71.8% | 44.2% |
| 5 Years | -89.4% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th18.56 | -10.74% | -12.88% |
| 3 Month | %th38.66 | 3.69% | -13.18% |
| 12 Month | %th40.21 | -11.21% | -26.79% |
| 5 Years | %th45.88 | -68.22% | -78.53% |
FAQs
Does Pacira BioSciences (PCRX) outperform the market?
No,
over the last 12 months PCRX made -16.02%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%.
Over the last 3 months PCRX made -3.82%, while XLV made -7.24%.
Performance Comparison PCRX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PCRX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -6.4% | -13.5% | 20.8% | -31% |
| US NASDAQ 100 | QQQ | -7.2% | -14.5% | 18.7% | -31% |
| German DAX 40 | DAX | -6.2% | -8.9% | 7.9% | -46% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -6% | -13.1% | 22.8% | -34% |
| Hongkong Hang Seng | HSI | -5.9% | -14.7% | 5.1% | -52% |
| India NIFTY 50 | INDA | -5.9% | -11% | 21.1% | -16% |
| Brasil Bovespa | EWZ | -7.7% | -16.7% | -3.7% | -29% |
PCRX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -7.9% | -15.7% | 14.2% | -45% |
| Consumer Discretionary | XLY | -4.8% | -10.6% | 29.5% | -36% |
| Consumer Staples | XLP | -2.9% | -7.3% | 22.6% | -25% |
| Energy | XLE | -2% | -12.4% | 26.3% | -12% |
| Financial | XLF | -6.5% | -12% | 17.7% | -45% |
| Health Care | XLV | -5.4% | -11% | 28% | -11% |
| Industrial | XLI | -5.9% | -12.7% | 14.2% | -40% |
| Materials | XLB | -4.4% | -10.5% | 21.5% | -19% |
| Real Estate | XLRE | -1.9% | -8.9% | 23.4% | -29% |
| Technology | XLK | -7.7% | -17.8% | 17.6% | -28% |
| Utilities | XLU | -3.9% | -9% | 17.5% | -40% |
| Aerospace & Defense | XAR | -8.3% | -18.8% | -0.6% | -69% |
| Biotech | XBI | -4.2% | -11% | 34.8% | -5% |
| Homebuilder | XHB | -4.6% | -15% | 32.1% | -17% |
| Retail | XRT | -3.3% | -10.3% | 29.5% | -22% |
PCRX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.9% | -14.0% | 30.1% | -6% |
| Natural Gas | UNG | 5.9% | 0.5% | 36% | -8% |
| Gold | GLD | -1.4% | -6.7% | 1% | -57% |
| Silver | SLV | -2.9% | -12.8% | 2.3% | -38% |
| Copper | CPER | -6.6% | -13.1% | 1.1% | -31% |
PCRX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -5.1% | -12.6% | 24% | -18% |
| iShares High Yield Corp. Bond | HYG | -4.3% | -10.8% | 21.8% | -27% |